Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BioLineRx Receives Orphan Drug Designation for Motixafortide for Pancreatic Cancer in Europe

americanpharmaceuticalreviewJanuary 19, 2020

Tag: BioLineRx , Motixafortide , Pancreatic cancer , Orphan Drug

PharmaSources Customer Service